infliximab-axxq Avsola
Selected indexed studies
- Comparison of Reference and Biosimilar Medications for Pediatric Noninfectious Uveitis. (Int Ophthalmol Clin, 2024) [PMID:39480210]
- Network meta-analysis of infliximab biosimilars for the treatment of rheumatoid arthritis. (Am J Health Syst Pharm, 2021) [PMID:33599738]
- Patterns of Infliximab Biosimilar Uptake for Medicare, Medicaid, and Private Insurance from 2016 to 2022. (Arthritis Rheumatol, 2024) [PMID:39077797]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Comparison of Reference and Biosimilar Medications for Pediatric Noninfectious Uveitis. (2024) pubmed
- Network meta-analysis of infliximab biosimilars for the treatment of rheumatoid arthritis. (2021) pubmed
- Patterns of Infliximab Biosimilar Uptake for Medicare, Medicaid, and Private Insurance from 2016 to 2022. (2024) pubmed
- Outcomes of the use of infliximab biosimilars in rheumatology and gastroenterology clinics. (2024) pubmed